Industry Collaborative Patent Interview Pilot Program takes effect as of November 1, 2021
E211027Y1 | Nov. 2021（E264）
For enabling patent examiners to promptly grasp the technical content of the patent applications for advanced technologies and for enhancing patent examination efficiency and quality and also for satisfying applicants’ needs for prompt patent granting to avail their patent portfolio building, Taiwan IPO formulated the Industry Collaborative Patent Interview Pilot Program and announced that the trial implementation of this program began from November 1, 2021 for one year. Taiwan IPO will evaluate the result of trial implementation and decide whether to renew or terminate this program after the trial period.
1. Applicants eligible for the program: The applicants of patent applications for inventions pertaining to advanced technology who have been notified by Taiwan IPO of a substantive examination but have not received office action or a written decision of patent examination.
2. Scope of advanced technologies: Advanced technologies under this program refer to stem cell regenerative medicine, medical care informatics, micro-LED display, quantum dots solar cells, neural network, quantum information, quantum computer, 3nm semiconductor manufacturing process, sophistication of chip packaging probe, twisted bilayer grapheme, third-generation semiconductor materials, artificial intelligence, Internet of Things, big data, blockchain, 3D printing, 5G mobile communication technology, and any other technologies decided individually by patent examiners. Please refer to Taiwan IPO’s website for details of this program through the link https://www.tipo.gov.tw/tw/cp-85-897801-406fd-1.html (Released 2021.10.27)